Procept Biorobotics Corp (PRCT)

Currency in USD
49.96
+1.45(+2.99%)
Closed·
After Hours
50.95+0.99(+1.98%)
·

PRCT Financial Summary

Key Ratios

P/E Ratio-32.75
Price/Book7.9
Debt / Equity21.02%
Return on Equity-27.62%
Dividend Yield0.00%
EBITDA-91.38M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 75.78
(+51.68% Upside)

Earnings

Latest Release
May 02, 2025
EPS / Forecast
-0.45 / -0.4907
Revenue / Forecast
69.16M / 65.43M
EPS Revisions
Last 90 days

FAQ

What were Procept Biorobotics's earnings for the latest quarter?

The Procept Biorobotics EPS (TTM) is -1.70. Procept Biorobotics reported sales of 69.16, net income of -24.74, and EPS of -0.45 for the latest quarter.

What was Procept Biorobotics's net income for the latest quarter?

Procept Biorobotics's net income for the latest quarter was -24.74.

How did Procept Biorobotics's performance compare year-over-year in the latest quarter?

The company's revenue moved from 68.24 in the previous quarter to 69.16 in the latest quarter, and net income moved from -18.86 to -24.74 compared to the previous quarter.

What is Procept Biorobotics's net profit margin on a TTM basis?

Procept Biorobotics's trailing twelve months (TTM) net profit margin is -40.72%.

How does Procept Biorobotics's debt to equity ratio compare to industry standards?

Procept Biorobotics's total debt-to-equity ratio is 21.02%.

What is Procept Biorobotics's return on investment on a TTM basis?

Procept Biorobotics's trailing twelve months (TTM) return on investment (ROI) is -27.62%.

Did Procept Biorobotics gain or lose cash last quarter?

In the latest quarter, Procept Biorobotics's net change in cash was -17.52 million.

What were Procept Biorobotics's total assets and liabilities in the latest quarter?

As of the latest quarter, Procept Biorobotics reported total assets of 519.38 million and total liabilities of 52.06 million.

How has Procept Biorobotics's total revenue grown this year?

Procept Biorobotics's total revenue was 68.24 in the previous quarter and 69.16 in the latest quarter.

What is Procept Biorobotics's gross margin on a TTM basis?

Procept Biorobotics's trailing twelve months (TTM) gross margin is 62.71%.

What was Procept Biorobotics's revenue per share for the latest quarter?

Procept Biorobotics's revenue per share for the latest quarter was 31.68.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.